Cargando…
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction
The downregulation of Pleckstrin Homology-Like Domain family A member 1 (PHLDA1) expression mediates resistance to targeted therapies in receptor tyrosine kinase-driven cancers. The restoration and maintenance of PHLDA1 levels in cancer cells thus constitutes a potential strategy to circumvent resis...
Autores principales: | Clayton, Natasha S., Carter, Edward P., Fearon, Abbie E., Heward, James A., Rodríguez Fernández, Lucía, Boughetane, Lina, Wilkes, Edmund H., Cutillas, Pedro R., Grose, Richard P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094256/ https://www.ncbi.nlm.nih.gov/pubmed/37047202 http://dx.doi.org/10.3390/ijms24076228 |
Ejemplares similares
-
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer
por: Fearon, Abbie E., et al.
Publicado: (2018) -
PHLDA1, another PHLDA family protein that inhibits Akt
por: Chen, Yu, et al.
Publicado: (2018) -
Correction: Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
por: Coetzee, Abigail S., et al.
Publicado: (2023) -
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
por: Coetzee, Abigail S., et al.
Publicado: (2022) -
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening
por: Hayat, Ateequllah, et al.
Publicado: (2023)